Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when enGene Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get ENGN alerts

About Lee G. Giguere

The proxy statement of enGene Therapeutics Inc. reports total compensation of $3,303,449 for Lee G. Giguere in fiscal 2024, including a base salary of $312,735. enGene Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at enGene Therapeutics Inc. includes Ron Cooper (CEO and Board Member), Ronald H. W. Cooper (CEO and Board Member), Ronald H.W. Cooper (CEO and Board Member) and 7 others.

Affiliation history

Company network

Leadership on record at enGene Therapeutics Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 enGene Therapeutics Inc. (ENGN) $312,735 $3,303,449

Recent activity

No call appearances or filed executive changes recorded yet.